1 | Differential expression of interferon inducible protein: Guanylate binding protein (GBP1 & GBP2) in severe dengue. | Vignesh Mariappan, Shalinda Adikari, Lokesh Shanmugam, Joshy M. Easow, Agieshkumar Balakrishna Pillai. Free Radical Biology and Medicine,Volume194, 2023, Pages 131-146 | Click Here |
2 | Analysis of gene expression profile for identification of novel gene signatures during dengue infection. | Jhansi Venkata Nagamani Josyula, Prathima Talari, Agiesh Kumar Balakrishna Pillai, Srinivasa Rao Mutheneni. Infectious Medicine, 2023, ISSN 2772-431X, | Click Here |
3 | A combination of Metformin and Epigallocatechin Gallate Potentiates Glioma Chemotherapy in vivo. | Shreyas S Kuduvalli, Daisy S Precilla, Anandraj Vaithy, Mugilarasi Purushothaman, Arumugam R Muralidharan, Agiesh Kumar B, Markus Mezger, Justin S Antony, Madhu Subramani, Biswajit Dubashi, Indrani Biswas, Kanive Parashiva Guruprasad and Anitha T. S. Front. Pharmacol, Volume 14,2023 | Click Here |
4 | Structural insights and shedding light on preferential interactions of dietary flavonoids with G-quadruplex DNA structures: A new horizon. | Sagar Bag, Mangal Deep Burman, Sudipta Bhowmik. Heliyon, Volume 9(3), 2023. 10.1016/j.heliyon.2023.e13959. | Click Here |
5 | Unravelling the Drug Encapsulation Ability of Functional DNA Origami Nanostructures: Current Understanding and Future Prospects on Targeted Drug Delivery. | Souvik Ghosal, Sagar Bag, Sudipta Bhowmik. Polymers, 2023, | Accepted (in press) |
6 | Current research status of anti-cancer peptides: Mechanism of action, production, and clinical applications | Chinnadurai RK, Khan N, Meghwanshi GK, Ponne S, Althobiti M, Kumar R. Current research status of anti-cancer peptides: Mechanism of action, production, and clinical applications. Biomed Pharmacother. 2023 Jun 11;164:114996. doi:10.1016/j.biopha.2023.114996. Epub ahead of print. PMID: 37311281. | Click Here |